Lunasin, with an arginine-glycine-aspartic acid motif, causes apoptosis to L1210 leukemia cells by activation of caspase-3

Molecular Nutrition and Food Research

Volumn 54, Issue 3, 2010, Pages 406-414

  Gonzalez de Mejia, Elvira ^a   Wang, Wenyi ^a   Dia, Vermont P ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Apoptosis; Leukemia; Lunasin; RGD motif; Soybean

Indexed keywords

ANTINEOPLASTIC AGENT; ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; CASPASE 3; CASPASE 8; CASPASE 9; GM2S 1 PROTEIN, GLYCINE MAX; GM2S-1 PROTEIN, GLYCINE MAX; HYDROLASE; OLIGOPEPTIDE; PLANT EXTRACT; SOYBEAN PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; DRUG STABILITY; ENZYME ACTIVATION; IC 50; ISOLATION AND PURIFICATION; LEUKEMIA L 1210; METABOLISM; MOUSE; PATHOLOGY; PHYTOTHERAPY; PROTEIN MOTIF; TIME; TUMOR CELL LINE;

AMINO ACID MOTIFS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STABILITY; ENZYME ACTIVATION; G2 PHASE; HYDROLASES; INHIBITORY CONCENTRATION 50; LEUKEMIA L1210; MICE; OLIGOPEPTIDES; PHYTOTHERAPY; PLANT EXTRACTS; SOYBEAN PROTEINS; TIME FACTORS;

GLYCINE MAX;

EID: 77649321216     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900073     Document Type: Article

References (39)

1. Wang, W., Gonzalez de Mejia, E., A new frontier in soy bioactive peptides that may prevent age-related chronic diseases. Comprehen. Rev. Food Sci. Food Safety 2005, 4, 63-78.
2. Galvez, A.-F., Chen, N., Macasieb, J., de Lumen, B.-O., Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res. 2001, 61, 7473-7478.
3. Jeong, H.-J., Lam, Y., de Lumen, B.-O., Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells. J. Agric. Food Chem. 2002, 50, 5903-5908.
4. Jeong, H.-J., Jeong, J.-B., Kim, D.-S., de Lumen, B.-O., Inhibition of core histone acetylation by the cancer preventive peptide lunasin. J. Agric. Food Chem. 2007, 55, 632-637.
5. Jeong, J.-B., Jeong, J.-H., Park, J.-H., Lee, S.-H. et al., Cancer-preventive peptide lunasin from Solanum nigrum L. inhibits acetylation of core histones H3 and H4 and phosphorylation of retinoblastoma protein (Rb). J. Agric. Food Chem. 2007, 55, 10707-10713.
6. Silva-Sanchez, C., Barba de la Rosa, A.-P., Leon-Galvan, M.-F., de Lumen, B. O. et al., Bioactive peptides in amaranth (Amaranthus hypochondriacus) seed. J. Agric. Food Chem. 2008,56,1233-1240.
7. Odani, S., Koide, T., Ono, T., Amino acid sequence of a soybean (Glycine max) seed polypeptide having a poly (L-aspartic acid) structure. J. Biol. Chem. 1987, 262, 10502-10505.
8. Galvez, A.-F., de Lumen, B.-O., A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells. Nat. Biotech. 1999, 17, 495-500.
9. Werb, C., ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997, 91, 439-442.
10. Meredith, J.-E., Schwartz, M.-A., Integrins adhesion and apoptosis. Trends Cell Bio. 1997, 7, 146-150.
11. Ruoslahti, E., RGD and other recognition sequences for integrins. Ann. Rev. Cell Dev. Biol. 1996, 12, 697-715.
12. Frisch, F.-M., Francis, H., Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 1994, 124, 619-626.
13. Chen, X., Wang, J., Fu, B., Yu, L., RGD-containing peptides trigger apoptosis in glomerular mesangial cells of adult human kidneys. Biochem. Biophys. Res. Commun. 1997, 234, 594-599.
14. Buckley, C.-D., Pilling, D., Henriquez, N.-V., Parsonage, G. et al., RGD peptides induce apoptosis by direct caspase-3 activation. Nature 1999, 397, 534-539.
15. Anuhadra, C.-D., Kanno, S., Hirano, S., RGD peptide-induced apoptosis in human leukemia HL-60 cells required caspase-3 activation. Cell Biol. Toxic. 2000, 16, 275-283.
16. Matsuki, K., Sasho, T., Nakagawa, K., Tahara, M. et al., RGD peptide-induced cell death of chondrocytes and synovial cells. J. Orthop. Sci. 2008, 13, 524-532.
17. Kasteng, F., Sobocki, P., Svedman, C., Lundkvist, J., Economic evaluations of leukemia: a review of the literature. Intl. J. Tech. Asses. Health Care 2007, 23, 43-53.
18. Brown, M.-L., Riley, G.-F., Schussler, N., Etzioni, R.-D., Estimating health care costs related to cancer treatment from SEER-Medicare data. Med. Care 2002, 40, 104-117.
19. Megias, C., Yust, M.-M., Pedroche, J., Lquari, H. et al., Purification of an ACE inhibitory peptide after hydrolysis of sunflower (Helianthus annuus L.) protein isolates. J. Agric. Food Chem. 2004, 52, 1928-1932.
20. de Mejia, E.-G., Vasconez, M., de Lumen, B.-O., Nelson, R., Lunasin concentration in different soybean genotypes, commercial soy protein, and isoflavone products. J. Agric. Food Chem. 2004, 52, 5882-5887.
21. Darzynkiewicz, Z., Juan, G., Bedner, E., in: Bonifacino, J.-S., Dasso, M., Harford, J. B., Lippincott-Schwartz, J., Yamada, K. M. (Eds.), Current Protocol in Cell Biology, John Wiley, Hoboken, NJ, USA 2003.
22. Dia, V.-P., Torres-Diaz, S., de Lumen, B.-O., Erdman, J.-W., Gonzalez de Mejia, E., Presence of lunasin in plasma of men after consumption of soy protein. J. Agric. Food Chem. 2009,57,1260-1266.
23. Lam, Y., Galvez, A., de Lumen, B.-O., Lunasin TM suppresses E1A-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines. Nutr. Cancer 2003, 47, 88-94.
24. Liu, J., Li, Y., Ren, W., Hu, W., Apoptosis of HL-60 cells induced by extracts from Narcissus tazetta var. chinensis. Cancer Lett. 2006, 242, 133-140.
25. Skladanowski, A., Come, M., Sabisz, M., Escargueil, A.-E., Larsen, A.-K., Down-regulation of DNA topoisomerase II-a leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule-interacting agents. Mol. Pharm. 2005, 68, 625-634.
26. Cohen, G. M., Caspases: the executioners of apoptosis. Biochem. J. 1997, 326, 1-16.
27. Alnemri, E.-S., Livingston, D.-J., Nicholson, G.-W., Salvesen, G. et al., Human ICE/CED-3 protease nomenclature. Cell 1996,87,171.
28. Salvensen, G.-S., Dixit, V.-M., Caspases: intracellular signaling by proteolysis. Cell 1997, 91, 443-446.
29. v Integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol. 1997, 15, 542-546.
30. Zitzmann, S., Ehemann, V., Schwab, M., Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. Cancer Res. 2000, 62, 5139-5143.
31. Chen, X., Conti, P.-S., Moats, R.-A., In vivo near-infrared fluorescence imaging of integrin avb3 in brain tumor xenografts. Cancer Res. 2004, 64, 8009-8014.
32. 3 expression in living mice. Bioconjugate Chem. 2005, 16, 1433-1441.
33. Haubner, B., Wester, H.-J., Weber, W.-A., Schwaiger, M., Radiotracer-based strategies to image angiogenesis. Q J. Nucl. Med. 2003, 47, 189-199.
34. Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J. et al., Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 2000, 60,722-727.
35. Arap, W., Pasqualini, R., Ruoslahti, E., Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998, 278, 377-380.
36. Ellerby, H.-M., Arap, W., Ellerby, L.-M., Kain, R. et al., Anti-cancer activity of targeted pro-apoptotic peptides. Nat. Med. 1999, 5, 1032-1038.
37. Chen, X., Plasencia, C., Hou, Y., Neamati, N., Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. J. Med. Chem. 2005, 48, 1098-1106.
38. Cao, Q., Li, Z.-B., Chen, K., Wu, Z. et al., Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide-paclitaxel conjugate in mice with breast cancer. Eur. J. Nucl. Molec. Imaging 2008, 35, 1489-1498.
39. Zhao, H., Wang, J.-C., Sun, Q.-S., Luo, C.-H., Zhang, Q., RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer. J. Drug Targ. 2009, 17, 10-18.